BRYCE TRANT: Open Payments
NPI 1720869324 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,832 in 53 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $429 · 2025 $1,832
Food & beverage: $1,647Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $452 |
| Sumitomo Pharma America, Inc. | 9 | $255 |
| PFIZER INC. | 9 | $174 |
| ABBVIE INC. | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $115 |
| SEAGEN INC. | 1 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $72 |
| TOLMAR, INC. | 3 | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $64 |
Products named: GEMTESA, XTANDI, ERLEADA, RYBREVANT, NEFFY, TREMFYA, Nubeqa, PYLARIFY.
Industry payments across VA — which companies pay providers there.
